Vestor Capital Increased Abbott Laboratories (ABT) Position By $567,777; Shorts at Ohio Valley Banc (OVBC) Lowered By 10.67%

May 27, 2018 - By Migdalia James

Abbott Laboratories (NYSE:ABT) Logo

Ohio Valley Banc Corp (NASDAQ:OVBC) had a decrease of 10.67% in short interest. OVBC’s SI was 69,500 shares in May as released by FINRA. Its down 10.67% from 77,800 shares previously. With 15,400 avg volume, 5 days are for Ohio Valley Banc Corp (NASDAQ:OVBC)’s short sellers to cover OVBC’s short positions. The SI to Ohio Valley Banc Corp’s float is 1.84%. The stock increased 0.51% or $0.25 during the last trading session, reaching $49.1. About 3,824 shares traded. Ohio Valley Banc Corp. (NASDAQ:OVBC) has risen 46.11% since May 27, 2017 and is uptrending. It has outperformed by 34.56% the S&P500.

Vestor Capital Llc increased Abbott Laboratories (ABT) stake by 5.16% reported in 2017Q4 SEC filing. Vestor Capital Llc acquired 9,961 shares as Abbott Laboratories (ABT)’s stock rose 5.88%. The Vestor Capital Llc holds 203,019 shares with $11.59M value, up from 193,058 last quarter. Abbott Laboratories now has $109.35B valuation. The stock decreased 0.22% or $0.14 during the last trading session, reaching $62.37. About 3.84M shares traded. Abbott Laboratories (NYSE:ABT) has risen 34.85% since May 27, 2017 and is uptrending. It has outperformed by 23.30% the S&P500.

Since May 2, 2018, it had 0 buys, and 1 insider sale for $9,469 activity. HOWE HAROLD A had sold 211 shares worth $9,469 on Wednesday, May 2.

Ohio Valley Banc Corp. operates as the bank holding firm for The Ohio Valley Bank Company that provides commercial and consumer banking services and products. The company has market cap of $231.74 million. The firm operates through two divisions, Banking and Consumer Finance. It has a 30.63 P/E ratio. It accepts various deposit products, including checking, savings, time, and money market accounts, as well as individual retirement accounts, demand deposits, NOW accounts, and certificates of deposit.

Investors sentiment increased to 2.63 in Q4 2017. Its up 1.07, from 1.56 in 2017Q3. It increased, as 2 investors sold Ohio Valley Banc Corp. shares while 6 reduced holdings. 6 funds opened positions while 15 raised stakes. 670,505 shares or 4.04% more from 644,472 shares in 2017Q3 were reported. Bank & Trust Of Ny Mellon holds 0% in Ohio Valley Banc Corp. (NASDAQ:OVBC) or 16,314 shares. Us Bank De holds 2,196 shares. Citigroup reported 607 shares or 0% of all its holdings. 9,944 are held by Wells Fargo And Co Mn. Meeder Asset Mgmt reported 0% in Ohio Valley Banc Corp. (NASDAQ:OVBC). Moreover, Group Inc has 0% invested in Ohio Valley Banc Corp. (NASDAQ:OVBC) for 2,749 shares. Blackrock invested 0% in Ohio Valley Banc Corp. (NASDAQ:OVBC). Assetmark invested in 6,251 shares or 0% of the stock. Geode Cap Management Limited Com stated it has 0% in Ohio Valley Banc Corp. (NASDAQ:OVBC). 650 are owned by Bankshares Of America De. Barclays Public Ltd holds 0% or 648 shares in its portfolio. California State Teachers Retirement System has 6,500 shares for 0% of their portfolio. Wesbanco Fincl Bank owns 98,284 shares for 0.27% of their portfolio. Deutsche Bank Ag has 0% invested in Ohio Valley Banc Corp. (NASDAQ:OVBC). Manufacturers Life Insurance The reported 4,045 shares stake.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 107 analyst reports since July 24, 2015 according to SRatingsIntel. Cowen & Co maintained Abbott Laboratories (NYSE:ABT) rating on Tuesday, August 15. Cowen & Co has “Buy” rating and $55.0 target. The firm has “Overweight” rating given on Thursday, January 25 by Morgan Stanley. The stock of Abbott Laboratories (NYSE:ABT) has “Hold” rating given on Monday, July 10 by BMO Capital Markets. The stock of Abbott Laboratories (NYSE:ABT) earned “Buy” rating by BTIG Research on Wednesday, June 21. JP Morgan upgraded Abbott Laboratories (NYSE:ABT) on Tuesday, January 2 to “Overweight” rating. The company was maintained on Monday, June 26 by RBC Capital Markets. Morgan Stanley maintained the stock with “Equal-Weight” rating in Tuesday, July 11 report. The rating was maintained by RBC Capital Markets with “Buy” on Wednesday, January 24. BMO Capital Markets maintained the shares of ABT in report on Wednesday, January 24 with “Buy” rating. The stock of Abbott Laboratories (NYSE:ABT) has “Hold” rating given on Thursday, August 31 by BMO Capital Markets.

Since December 14, 2017, it had 1 insider purchase, and 21 selling transactions for $23.88 million activity. Another trade for 2,150 shares valued at $125,909 was made by Bracken Sharon J on Friday, May 4. 11,106 shares were sold by Fussell Stephen R, worth $667,804. $183,579 worth of Abbott Laboratories (NYSE:ABT) was sold by Watkin Jared. Another trade for 1,645 shares valued at $96,728 was sold by BIRD ROGER. Ford Robert B sold 42,665 shares worth $2.69 million. $27,213 worth of stock was sold by PEDERSON MICHAEL J on Friday, February 16. Funck Robert E had sold 1,220 shares worth $71,970 on Wednesday, February 28.

Ohio Valley Banc Corp. (NASDAQ:OVBC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts